Recombinant vascular endothelial growth factor165 gene therapy improves anastomotic healing in an animal model of ischemic esophagogastrostomy

Diseases of the Esophagus

Volumn 25, Issue 5, 2012, Pages 456-464

  Enestvedt, C K ^a   Hosack, L ^a   Hoppo, T ^d   Perry, K A ^c   O'Rourke, R W ^a   Winn, S R ^b   Hunter, J G ^a   Jobe, B A ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anastomosis; Esophagus; Healing; Ischemia; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; RECOMBINANT VASCULOTROPIN 165; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165;

ANASTOMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESOPHAGOGASTROSTOMY; ESOPHAGUS ANASTOMOSIS; ESOPHAGUS PRESSURE; GASTROJEJUNOSTOMY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH FUNDUS; SURGICAL WOUND; TISSUE BLOOD FLOW; WOUND HEALING;

ANASTOMOSIS, SURGICAL; ANASTOMOTIC LEAK; ANIMALS; DIDELPHIS; DISEASE MODELS, ANIMAL; ESOPHAGECTOMY; ESOPHAGUS; GASTRECTOMY; GENETIC THERAPY; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84863474594     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01247.x     Document Type: Article

References (46)

1. Docherty J G, McGregor J R, Akyol A M etal. Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group. Ann Surg 1995; 221: 176-84.
2. Walker K G, Bell S W, Rickard M J etal. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 2004; 240: 255-9.
3. McArdle C S, McMillan D C, Hole D J. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005; 92: 1150-4.
4. Brisinda G, Vanella S, Cadeddu F, Mazzeo P. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009; 208: 1152-3; author reply 1153-4.
5. Umpleby H C, Fermor B, Symes M O, Williamson R C. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984; 71: 659-63.
6. Skipper D, Cooper A J, Marston J E, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987; 74: 1049-52.
7. Gonzalez R, Sarr M G, Smith C D etal. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg 2007; 204: 47-55.
8. Vin Y, Sima C S, Getrajdman G I etal. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 2008; 207: 490-8.
9. Luketich J D, Alvelo-Rivera M, Buenaventura P O etal. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003; 238: 486-94; discussion 494-5.
10. Briel J W, Tamhankar A P, Hagen J A etal. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004; 198: 536-41; discussion 541-2.
11. Urschel J D. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review. Am J Surg 1995; 169: 634-40.
12. Lorentz T, Fok M, Wong J. Anastomotic leakage after resection and bypass for esophageal cancer: lessons learned from the past. World J Surg 1989; 13: 472-7.
13. Miyazaki T, Kuwano H, Kato H etal. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg 2002; 26: 1319-23.
14. Posma L A, Bleichrodt R P, Lomme R M etal. Early anastomotic repair in the rat intestine is affected by transient preoperative mesenteric ischemia. J Gastrointest Surg 2009; 13: 1099-106.
15. Reavis K M, Chang E Y, Hunter J G, Jobe B A. Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses. Ann Surg 2005; 241: 736-45; discussion 745-7.
16. Berse B, Brown L F, Van de Water L etal. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3: 211-20.
17. Brown L F, Yeo K T, Berse B etal. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-9.
18. Connolly D T, Heuvelman D M, Nelson R etal. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
19. Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
20. Corral C J, Siddiqui A, Wu L etal. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999; 134: 200-5.
21. Leung D W, Cachianes G, Kuang W J etal. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
22. Senger D R, Ledbetter S R, Claffey K P etal. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149: 293-305.
23. Banbury J, Siemionow M, Porvasnik S etal. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000; 106: 1541-6.
24. Kryger Z, Zhang F, Dogan T etal. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53: 234-9.
25. Lineaweaver W C, Lei M P, Mustain W etal. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg 2004; 239: 866-73; discussion 873-5.
26. Padubidri A, Browne E Jr. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 1996; 37: 604-11.
27. Seify H, Bilkay U, Jones G. Improvement of TRAM flap viability using human VEGF-induced angiogenesis: a comparative study of delay techniques. Plast Reconstr Surg 2003; 112: 1032-9.
28. Enestvedt C K, Hosack L, Winn S R etal. VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model. J Gastrointest Surg 2008; 12: 1762-70; discussion 1771-2.
29. Forse R A, MacDonald P H, Mercer C D. Anastomotic and regional blood flow following esophagogastrectomy in an opossum model. J Invest Surg 1999; 12: 45-52.
30. Rozen S, Skaletsky H J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, (eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, 2000; 365-86.
31. Pfaffl M W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
32. Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8.
33. Weidner N, Folkman J, Pozza F etal. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
34. Shepherd A P, Riedel G L. Continuous measurement of intestinal mucosal blood flow by laser-Doppler velocimetry. Am J Physiol 1982; 242: G668-72.
35. Machens H G, Salehi J, Weich H etal. Angiogenic effects of injected VEGF165 and sVEGFR-1 (sFLT-1) in a rat flap model. J Surg Res 2003; 111: 136-42.
36. Shima D T, Deutsch U, D'Amore P A. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995; 370: 203-8.
37. Zacchigna S, Papa G, Antonini A etal. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am J Pathol 2005; 167: 981-91.
38. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002; 9: 1647-52.
39. Ohlfest J R, Freese A B, Largaespada D A. Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies. Curr Gene Ther 2005; 5: 629-41.
40. Winn S R, Chen J C, Gong X etal. Non-viral-mediated gene therapy approaches for bone repair. Orthod Craniofac Res 2005; 8: 183-90.
41. Kleespies A, Guba M, Jauch K W, Bruns C J. Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 2004; 87: 95-104.
42. McDonnell C O, Harmey J H, Bouchier-Hayes D J, Walsh T N. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer. Br J Surg 2001; 88: 1105-9.
43. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
44. Michaels J V, Levine J P, Hazen A etal. Biologic brachytherapy: ex vivo transduction of microvascular beds for efficient, targeted gene therapy. Plast Reconstr Surg 2006; 118: 54-65; discussion 66-8.
45. Tsurumi Y, Takeshita S, Chen D etal. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-90.
46. Lee M, Rentz J, Bikram M etal. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Gene Ther 2003; 10: 1535-42.